Results 241 to 250 of about 35,888 (296)

Prenatal opioid exposure, and health, social and educational outcomes for school‐aged children: A systematic review

Addiction, EarlyView.
Abstract Background and aims Recent decades have seen a rise in the number of pregnancies exposed to opioids. Whilst evidence of the impact of such exposure on pregnancy and infant outcomes is fairly robust, the impact of prenatal opioid exposure (POE) on longer‐term outcomes for children and young people remains unclear.
Louise Marryat, Dawood Gashgari, Shona Shinwell, Vicky Mitchell, Catriona Connell, Gale Macleod, Senga Robertson, Anne Whittaker, Alison McFadden   +8 more
wiley   +1 more source

The Impact of Prolonged Exposure Therapy on Posttraumatic Stress Disorder Symptom Clusters in Adults Maintained on Medications for Opioid Use Disorder. [PDF]

Clin Psychol Psychother
Giannini JA, Badger GJ, Cole R, Peck KR.
europepmc   +1 more source

The Cannabis Research Image Database (CRESIDA): A standardized and validated image set for studying cannabis cue reactivity

Addiction, EarlyView.
Abstract Background and aims Cannabis cue reactivity paradigms are instrumental in studying the behavioral and neurocognitive mechanisms of cannabis use and cannabis use disorders; however, image sets used for cannabis cue reactivity paradigms vary between studies, and the lack of reliability and validity assessment hinders the quality of evidence they
Janna Cousijn, Emese Kroon, Chao Suo, Tom P. Freeman, Chandni Hindocha, Marianna Quinones‐Valera, Valentina Lorenzetti   +6 more
wiley   +1 more source

Telemedicine to improve access to medications for opioid use disorder in Illinois, 2022-2024. [PDF]

Int J Drug Policy
Gressick K, Fiorillo M, Richardson S, Bruni M, Brenner S, Hua M, Prachand N, Gastala N.   +7 more
europepmc   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source

Situational confidence and recovery capital among justice-involved adults receiving medications for opioid use disorder in a jail-based setting. [PDF]

Health Justice
Obekpa EO, He X, Betancur A, Gallardo KR, Rodriguez SA, McCurdy SA, Wilkerson JM.   +6 more
europepmc   +1 more source

Craving and personal functioning as mediators of extended‐release buprenorphine efficacy: A four‐way decomposition analysis from a randomised trial

Addiction, EarlyView.
Abstract Aims To investigate whether the treatment effect of extended‐release buprenorphine (BUP‐XR) on opioid‐free days in opioid use disorder (OUD) is mediated by reductions in opioid craving and improvements in personal functioning. Design and setting Exploratory causal mediation analysis using VanderWeele's four‐way decomposition framework in a 24 ...
John Marsden, Mike Kelleher, Fiona Cowden, Edward Day, Jonathan Dewhurst, Rachel Evans, Eilish Gilvarry, Natalie Lowry, Luke Mitcheson, Robert Murray, Sophie Quarshie, Zoë Hoare   +11 more
wiley   +1 more source

Overdose reversal through peer intervention: Findings from the naloxone prospective outcome research study (NalPORS) on the effectiveness of overdose response by people who use opioids in the United Kingdom and Sweden

Addiction, EarlyView.
Abstract Background/aims Take‐home naloxone (THN) programmes have been introduced in many European countries to provide non‐medically trained people who are likely to witness an opioid overdose, including people who use opioids, with a naloxone kit and training.
Nicola Metrebian, Teodora Dascal, Clare Mackie, Rose Tinch‐Taylor, Ben Carter, Joanne Neale, Mariana Gonzalez Utrilla, Ed Day, Joar Guterstam, Kirsten Horsburgh, Martin Kåberg, Mike Kelleher, Soraya Mayet, Josie Smith, Desiree Eide, Elin Holmén, Rebecca McDonald, Stephen Parkin, Henrik Thiesen, John Strang, NalPORS Research Team, Dean Acreman, Shabana Akhtar, Louise Aitken, Martin Anderson, James Cassidy, Sarah Cosgrove, Jo Grayer, Michelle Hughes, Louise Horn, Anika Miah, John Pratt   +31 more
wiley   +1 more source

Medications for opioid use disorder in traditional medicare beneficiaries: associations with age. [PDF]

Health Aff Sch
Ganz DA, Lai J, Cantor JH, Agniel D, Simon K, Stein BD, Taylor EA.   +6 more
europepmc   +1 more source

Beyond treatment response: Injection‐site reactions as part of the extended‐release buprenorphine experience

Addiction, EarlyView.
Julien Cabé, Georges Brousse
wiley   +1 more source